Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NervGen Pharma Corp NGENF


Primary Symbol: V.NGEN

NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in discovery, development and commercialization of pharmaceutical products for the treatment of nervous system damage due to injury or disease. The Company is advancing its lead compound, NVG-291, for the treatment of spinal cord injury (SCI), Alzheimer’s disease (AD) and multiple sclerosis (MS). Its NVG-291 is a therapeutic peptide, which is a mimetic of the intracellular domain of protein tyrosine phosphatase, a cell surface receptor known to interact with chondroitin sulfate proteoglycans (CSPGs) and to be involved in the regulation of neuroplasticity and central nervous system repair. It has also initiated preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury. The Company's wholly owned subsidiaries include NervGen US Inc. and NervGen Australia Pty Ltd.


TSXV:NGEN - Post by User

Post by stargazer1on Jan 08, 2024 11:16am
240 Views
Post# 35815669

Under $2, But: SHOOTING UPWARD 2 days now. Buy? Buy?

Under $2, But: SHOOTING UPWARD 2 days now. Buy? Buy?So far no new press release. NGENF has fallen for days and days since it went up on hugh volumes. After the hugh volumes, it has been dropping on volumes of a few thousand shares. But now volume is picking up, even though only moderately.

Friday it picked up more, and that was while it ticked higher and higher. Today, just in these morning hours, the volume is gaining momentum and the stock is moving straight up.

May not mean anything. No new press release, BUT ... Increasing volume on Increasing Price?

Maybe a press release is on the near by horizon?

I may kick myself, but I'm selling more of my other stocks and buying more NGENF.

If anyone else wants to join me???
<< Previous
Bullboard Posts
Next >>